Quick Answer
BetterLife Pharma Inc. reported Cash and Equivalents of $74.8 thousand for fiscal year 2019.
BetterLife Pharma Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2019 | $74.8K | -5.7% |
| 2018 | $79.3K | -46.1% |
| 2017 | $147.0K | +105.2% |
| 2016 | $71.6K | +8438.6% |
| 2015 | $839.00 | -10.3% |
| 2014 | $935.00 | +96.8% |
| 2013 | $475.00 | -77.0% |
| 2012 | $2.1K | -86.3% |
| 2011 | $15.0K | -20.8% |
| 2010 | $19.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| April 30, 2019 | $45.4K | -97.6% | -39.3% |
| January 31, 2019 | $74.8K | -5.7% | -81.6% |
| October 31, 2018 | $406.9K | +62.5% | -14.2% |
| July 31, 2018 | $474.5K | +4672.1% | -75.3% |
| April 30, 2018 | $1.92M | +4019.6% | +2325.8% |
| January 31, 2018 | $79.3K | -29.5% | -68.3% |
| October 31, 2017 | $250.4K | +21.2% | +2418.2% |
| July 31, 2017 | $9.9K | +226.0% | -78.7% |
- BetterLife Pharma Inc. showed a decrease of -5.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2019 period, BetterLife Pharma Inc.’s cash and equivalents has grown by 294.1% (from $19.0 thousand to $74.8 thousand).
- The most recent figure is from BetterLife Pharma Inc.’s fiscal year 2018 report (Form 10-K), filed with the SEC on May 3, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: